HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David T W Jones Selected Research

Phosphotransferases (Kinase)

1/2022Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.
1/2020Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.
1/2020Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases.
1/2018Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.
1/2017Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.
11/2008Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David T W Jones Research Topics

Disease

98Neoplasms (Cancer)
02/2022 - 08/2009
34Glioma (Gliomas)
10/2022 - 09/2012
28Medulloblastoma
01/2021 - 04/2012
22Astrocytoma (Pilocytic Astrocytoma)
11/2022 - 11/2008
16Glioblastoma (Glioblastoma Multiforme)
06/2021 - 08/2009
10Brain Neoplasms (Brain Tumor)
11/2022 - 03/2013
7Carcinogenesis
01/2022 - 04/2012
6Oligodendroglioma
06/2021 - 02/2014
5Primitive Neuroectodermal Tumors (PNET)
01/2021 - 01/2016
5Ependymoma
01/2019 - 01/2016
4Disease Progression
06/2022 - 05/2013
4Meningioma (Meningiomas)
12/2021 - 03/2013
4Genomic Instability
11/2021 - 06/2016
4Diffuse Intrinsic Pontine Glioma
01/2021 - 01/2017
3Neuroepithelial Neoplasms (Gliomatosis Cerebri)
01/2017 - 01/2016
2Neuroblastoma
09/2021 - 01/2021
2Exanthema (Rash)
09/2020 - 01/2019
2Pinealoma (Pineoblastoma)
01/2020 - 01/2018
2Nervous System Neoplasms (Neoplasms, Nervous System)
01/2019 - 03/2015
2Typical Teratoid Rhabdoid Tumor
01/2019 - 12/2012
2Ganglioglioma
10/2018 - 01/2017
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 01/2016
2Chromothripsis
06/2016 - 08/2012
2Neoplasm Metastasis (Metastasis)
01/2016 - 11/2013
2Intellectual Disability (Idiocy)
11/2012 - 01/2012
1Tuberous Sclerosis (Bourneville's Disease)
11/2022
1Pleomorphic Adenoma
11/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2021
1Turcot syndrome
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Paronychia
09/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Neurofibromatoses (Neurofibromatosis)
01/2019

Drug/Important Bio-Agent (IBA)

19Biological ProductsIBA
01/2021 - 04/2012
16Biomarkers (Surrogate Marker)IBA
06/2022 - 05/2013
15Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2009
15DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2013
13RNA (Ribonucleic Acid)IBA
11/2021 - 08/2012
12Pharmaceutical PreparationsIBA
02/2022 - 06/2011
12Histones (Histone)IBA
12/2020 - 01/2012
10ChromatinIBA
01/2019 - 01/2012
8dipinacoline glutamateIBA
01/2021 - 01/2016
7Formaldehyde (Formol)FDA Link
11/2019 - 11/2013
7ParaffinIBA
11/2019 - 11/2013
6Phosphotransferases (Kinase)IBA
01/2022 - 11/2008
6Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2021 - 08/2009
6Messenger RNA (mRNA)IBA
01/2020 - 07/2011
5MicroRNAs (MicroRNA)IBA
01/2021 - 12/2012
4Mitogen-Activated Protein KinasesIBA
09/2020 - 08/2013
4NucleotidesIBA
12/2019 - 01/2016
4Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 09/2012
32,6-dinitrotoluene (DNT)IBA
10/2022 - 01/2017
3Transcription Factors (Transcription Factor)IBA
01/2022 - 07/2014
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 12/2013
3Small Interfering RNA (siRNA)IBA
11/2019 - 02/2014
3hydrogen sulfite (bisulfite)IBA
05/2019 - 09/2012
3MethyltransferasesIBA
01/2019 - 01/2018
2Protein Isoforms (Isoforms)IBA
01/2022 - 07/2014
2ProteomeIBA
01/2021 - 01/2020
2CateninsIBA
01/2019 - 08/2012
2Lysine (L-Lysine)FDA Link
11/2018 - 03/2013
2RNA Helicases (RNA Helicase)IBA
05/2016 - 08/2012
2Codon (Codons)IBA
01/2016 - 08/2009
1trans-sodium crocetinate (crocetin)IBA
11/2022
1Sirolimus (Rapamycin)FDA Link
11/2022
1human MIRN376A1 microRNAIBA
06/2022
1tyrosine receptor (receptor, tyrosine)IBA
01/2022
1Proto-Oncogene Proteins c-etsIBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2021
1Histone Deacetylase InhibitorsIBA
09/2021
1eprenetapoptIBA
09/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Arsenic Trioxide (Trisenox)FDA Link
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1entrectinibIBA
12/2020
1Valine (L-Valine)FDA Link
12/2020
1Arginine (L-Arginine)FDA Link
12/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2020
1trametinibIBA
09/2020
1entinostat (MS 275)IBA
06/2020
1NivolumabIBA
06/2020
1NeurocalcinIBA
01/2020
1Basic-Leucine Zipper Transcription FactorsIBA
01/2020
1ponatinibIBA
11/2019
1LB100IBA
11/2019
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2019
1Conditioned Culture MediaIBA
01/2019
1AZD 6244IBA
01/2019
11,4-dinitro-2-methyl-2-buteneIBA
01/2019

Therapy/Procedure

42Therapeutics
02/2022 - 04/2011
9Drug Therapy (Chemotherapy)
01/2022 - 08/2012
5Precision Medicine
06/2022 - 01/2016
4Radiotherapy
01/2021 - 01/2016
3Investigational Therapies (Experimental Therapy)
01/2019 - 01/2016
3Chemoradiotherapy
01/2018 - 01/2016
2Aftercare (After-Treatment)
01/2021 - 01/2016
2Ligation
11/2014 - 05/2013
1Cranial Irradiation
01/2021
1Combined Modality Therapy
12/2020
1Drug Tapering
09/2020